Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Quality of Life Research
Published in: Quality of Life Research 9/2010

Open Access 01-11-2010

Patient treatment satisfaction after switching to NovoMix® 30 (BIAsp 30) in the IMPROVE™ study: an analysis of the influence of prior and current treatment factors

Authors: Meryl Brod, Paul Valensi, Joseph A. Shaban, Don M. Bushnell, Torsten L. Christensen

Published in: Quality of Life Research | Issue 9/2010

Login to get access

Abstract

Purpose

Understanding treatment satisfaction (TS) for diabetes is increasingly important as treatment options increase. This study examines treatment satisfaction with NovoMix® 30 in an observational study in patients with type 2 diabetes.

Methods

The DiabMedSat assesses Overall, Treatment Burden, Symptom and Efficacy Treatment Satisfaction. The impact of type of pretreatment variables on TS was examined by ANOVA at baseline and week 26. Satisfaction at week 26 was examined by t-test and effect size. Linear regression models examined impact of prior treatment factors (age, gender, duration of diabetes, type of prior treatment and diabetes-related comorbidities) and current treatment factors (weight gain, hypoglycemic events, reaching therapeutic goal) on TS.

Results

The data set comprised 17,488 persons. Prior treatment with insulin had a more positive impact on baseline satisfaction. At week 26, there were no differences between type of prior treatment groups in Overall, Symptoms and Burden TS. Current treatment with NovoMix 30 significantly improved TS. Regression analyses examining the combined effect of pretreatment factors and current treatment factors found that all factors except for age-impacted TS although the domains impacted varied.

Conclusions

Patients treated with NovoMix 30 reported improved treatment satisfaction, and the improvement is considered clinically meaningful to patients.
Literature
1.
Albrecht, G., & Hoogstraten, J. (1998). Satisfaction as a determinant of compliance. Community Dentistry and Oral Epidemiology, 26(2), 139–146.CrossRefPubMed
2.
Atkinson, M. J., Kumar, R., Cappelleri, J. C., & Hass, S. L. (2005). Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM version II) among outpatient pharmacy consumers. Value In Health, 8(Suppl 1), S9–S24.CrossRefPubMed
3.
Menzin, J., Langley-Hawthorne, C., Friedman, M., Boulanger, L., & Cavanaugh, R. (2001). Potential short-term economic benefits of improved glycemic control: A managed care perspective. Diabetes Care, 24(1), 51–55.CrossRefPubMed
4.
Hogan, P., Dall, T., & Nikolov, P. (2003). Economic costs of diabetes in the US in 2002. Diabetes Care, 26(3), 917–932.CrossRefPubMed
5.
Anderson, R. T., Marrero, D., Skovlund, S. E., Cramer, J., & Schwartz, S. (2003). Self-reported compliance with insulin injection therapy in subjects with type 1 and 2 diabetes [abstract]. Diabetologia, 46(Suppl 2), A275.
6.
Clark, C. M., Jr., Snyder, J. W., Meek, R. L., Stutz, L. M., & Parkin, C. G. (2001). A systematic approach to risk stratification and intervention within a managed care environment improves diabetes outcomes and patient satisfaction. Diabetes Care, 24(6), 1079–1086.CrossRefPubMed
7.
Rosenstock, J., Cappelleri, J. C., Bolinder, B., & Gerber, R. A. (2004). Patient satisfaction and glycemic control after 1 year with inhaled insulin (Exubera) in patients with type 1 or type 2 diabetes. Diabetes Care, 27(6), 1318–1323.CrossRefPubMed
8.
Centers for Disease Control and Prevention (CDC). (2008). National Center for Health Statistics, Division of Health Interview Statistics, data from the National Health Interview Survey. Age-adjusted percentage of adults with diabetes using diabetes medication, by type of medication, United States, 1997–2008. Data computed by personnel in the Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion. http://​www.​cdc.​gov/​diabetes/​statistics/​meduse/​fig2.​htm. Accessed March 2, 2010.
9.
Meece, J. (2006). Dispelling myths and removing barriers about insulin in type 2 diabetes. The Diabetes Educator, 32, 9S–18S.CrossRefPubMed
10.
Fitzgerald, J. T., Gruppen, L. D., Anderson, R. M., Funnell, M. M., Jacober, S. J., Grunberger, G., et al. (2000). The influence of treatment modality and ethnicity on attitudes in type 2 diabetes. Diabetes Care, 23, 313–318.CrossRefPubMed
11.
Hunt, L. M., Valenzuela, M. A., & Pugh, J. A. (1997). NIDDM patients’ fears and hopes about insulin therapy. The basis of patient reluctance. Diabetes Care, 20(3), 292–298.CrossRefPubMed
12.
Zambanini, A., Newson, R. B., Maisey, M., & Feher, M. D. (1999). Injection related anxiety in insulin-treated diabetes. Diabetes Research and Clinical Practice, 46(3), 239–246.CrossRefPubMed
13.
Polonsky, W. H., Fisher, L., Guzman, S., Villa-Caballero, L., & Edelman, S. V. (2005). Psychological insulin resistance in patients with type 2 diabetes: The scope of the problem. Diabetes Care, 28(10), 2543–2545.CrossRefPubMed
14.
Weijman, I., Ros, W. J., Rutten, G. E., Schaufeli, W. B., Schabracq, M. J., & Winnubst, J. A. (2005). Frequency and perceived burden of diabetes self-management activities in employees with insulin-treated diabetes: relationships with health outcomes. Diabetes Research and Clinical Practice, 68(1), 56–64.CrossRefPubMed
15.
Anderson, R. T., Skovlund, S. E., Marrero, D., Levine, D. W., Meadows, K., Brod, M., et al. (2004). Development and validation of the insulin treatment satisfaction questionnaire. Clinical Therapeutics, 26(4), 565–578.CrossRefPubMed
16.
Brod, M., Cobden, D., Lammert, M., Bushnell, D., & Raskin, P. (2007). Examining correlates of treatment satisfaction for injectable insulin in type 2 diabetes: Lessons learned from a clinical trial comparing biphasic and basal analogues. Health and Quality of Life Outcomes, 5, 8.CrossRefPubMed
17.
Cappelleri, J. C., Gerber, R. A., Kourides, I. A., & Gelfand, R. A. (2000). Development and factor analysis of a questionnaire to measure patient satisfaction with injected and inhaled insulin for type 1 diabetes. Diabetes Care, 23(12), 1799–1803.CrossRefPubMed
18.
Petterson, T., Lee, P., Hollis, S., Young, B., Newton, P., & Dornan, T. (1998). Wellbeing and treatment satisfaction in older people with diabetes. Diabetes Care, 21(6), 930–935.CrossRefPubMed
19.
Redekop, W. K., Koopmanschap, M. A., Stolk, R. P., Rutten, G. E., Wolffenbuttel, B. H., & Niessen, L. W. (2002). Health-related quality of life and treatment satisfaction in Dutch patients with Type 2 diabetes. Diabetes Care, 25(3), 458–463.CrossRefPubMed
20.
Taylor, M. D., Frier, B. M., Gold, A. E., & Deary, I. J. (2003). Psychosocial factors and diabetes-related outcomes following diagnosis of type 1 diabetes in adults: The Edinburgh Prospective Diabetes Study. Diabetic Medicine, 20(2), 135–146.CrossRefPubMed
21.
Franciosi, M., Maione, A., Pomili, B., Amoretti, R., Busetto, E., Capani, F., et al. (2010). Correlates of quality of life in adults with type 1 diabetes treated with continuous subcutaneous insulin injection. Nutrition, Metabolism and Cardiovascular Disease, 20(1), 7–14.CrossRef
22.
Mendes, A. B., Fittipaldi, J. A., Neves, R. C., Chacra, A. R., & Moreira, E. D., Jr. (2009). Prevalence and correlates of inadequate glycaemic control: results from a nationwide survey in 6, 671 adults with diabetes in Brazil. Acta Diabetologica,. doi:10.​1007/​s00592-009-0138-z.PubMed
23.
Biderman, A., Noff, E., Harris, S. B., Friedman, N., & Levy, A. (2009). Treatment satisfaction of diabetic patients: What are the contributing factors? Family Practice, 26(2), 102–108.CrossRefPubMed
24.
Gerber, R. A., Cappelleri, J. C., Kourides, I. A., & Gelfand, R. A. (2001). Treatment satisfaction with inhaled insulin in patients with type 1 diabetes: A randomized controlled trial. Diabetes Care, 24(9), 1556–1559.CrossRefPubMed
25.
Hollander, P. A., Blonde, L., Rowe, R., Mehta, A. E., Milburn, J. L., Hershon, K. S., et al. (2004). Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes: Results of a 6-month, randomized, comparative trial. Diabetes Care, 27(10), 2356–2362.CrossRefPubMed
26.
Quattrin, T., Bélanger, A., Bohannon, N. J., & Schwartz, S. L. (2004). Exubera Phase III Study Group. Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial. Diabetes Care, 27(11), 2622–2627.CrossRefPubMed
27.
Raskin, P., Bode, P. W., Marks, J. B., Hirsch, I. B., Weinstein, R. L., McGill, J. B., et al. (2003). Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: A randomized, parallel-group, 24 week study. Diabetes Care, 26(9), 2598–2603.CrossRefPubMed
28.
Weintrob, N., Benzaquen, H., Galatzer, A., Shalitin, S., Lazar, L., Fayman, G., et al. (2003). Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: A randomized open crossover trial. Pediatrics, 112(3 Pt 1), 559–564.CrossRefPubMed
29.
Bott, U., Ebrahim, S., Hirchberger, S., & Skovlund, S. E. (2003). Effect of the rapid-acting insulin analogue insulin aspart on quality of life and treatment satisfaction in patients with type 1 diabetes. Diabetes Medicine, 209(8), 626–634.CrossRef
30.
Renner, R., Pfutzner, A., Trautmann, M., Harzer, O., Sauter, K., & Landgraf, R. (1999). Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Diabetes Care, 22(5), 784–788.CrossRefPubMed
31.
Valensi, P., Benroubi, M., Borzi, V., Gumprecht, J., Kawamori, R., Shaban, J., et al. (2009). Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix 30) in routine care: Safety and effectiveness in patients with type 2 diabetes in the IMPROVE observational study. International Journal of Clinical Practice, 63(3), 522–531.CrossRefPubMed
32.
Ahlgren, S. S., Shultz, J. A., Massey, L. K., Hicks, B. C., & Wysham, C. (2004). Development of a preliminary diabetes dietary satisfaction and outcomes measure for patients with type 2 diabetes. Quality of Life Research, 13(4), 819–832.CrossRefPubMed
33.
Nicolucci, A., Cucinotta, D., Squatrito, S., Lapolla, A., Musacchio, N., Leotta, S., et al. (2009). Clinical and socio-economic correlates of quality of life and treatment satisfaction in patients with type 2 diabetes. Nutrition, Metabolism and Cardiovascular Disease, 19(1), 45–53.CrossRef
34.
Brod, M., Kongsø, J. H., Lessard, S., & Christensen, T. L. (2009). Psychological insulin resistance: Patient beliefs and implications for diabetes management. Quality of Life Research, 18(1), 23–32.CrossRefPubMed
35.
Wolffenbuttel, B. H., Drossaert, C. H., & Visser, A. P. (1993). Determinants of injecting insulin in elderly patients with type II diabetes mellitus. Patient Education and Counseling, 22(3), 117–125.CrossRefPubMed
36.
Bryden, K. S., Neil, A., Mayou, R. A., Peveler, R. C., Fairburn, C. G., & Dunger, D. B. (1999). Eating habits, body weight, and insulin misuse. A longitudinal study of teenagers and young adults with type 1 diabetes. Diabetes Care, 22(12), 1956–1960.CrossRefPubMed
37.
Polonsky, W. H., Anderson, B. J., Lohrer, P. A., Aponte, J. E., Jacobson, A. M., & Cole, C. F. (1994). Insulin omission in women with IDDM. Diabetes Care, 17(10), 1178–1185.CrossRefPubMed
38.
Albu, J., & Raja-Khan, N. (2003). The management of the obese diabetic patient. Primary Care: Clinics in Office Practice, 30(2), 465–491.CrossRefPubMed
39.
Alvarez Guisasola, F., Tofé Povedano, S., Krishnarajah, G., Lyu, R., Mavros, P., & Yin, D. (2008). Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: Findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study. Diabetes. Obesity and Metabolism, 10(Suppl 1), 25–32.CrossRef
40.
Brod, M., Skovlund, S. E., & Wittrup-Jensen, K. U. (2006). Measuring the impact of diabetes through patient report of treatment satisfaction, productivity and symptom experience. Quality of Life Research, 15(3), 481–491.CrossRefPubMed
41.
Brod, M., Christensen, T., Kongso, J. H., & Bushnell, D. M. (2009). Examining and interpreting responsiveness of the Diabetes Medication Satisfaction measure. Journal of Medical Economics, 12(4), 309–316.CrossRefPubMed
42.
Wild, D., Grove, A., Martin, M., Eremenco, S., McElroy, S., Verjee-Lorenz, A., et al. (2005). Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: Report of the ISPOR Task Force for Translation and Cultural Adaptation. Value in Health, 8(2), 94–104.CrossRefPubMed
43.
Ring, L., Hofer, S., Heuston, F., Harris, D., & O’Boyle, C. A. (2005). Response shift masks the treatment impact on patient reported outcomes (PROs): The example of individual quality of life in edentulous patients. Health and Quality of Life Outcomes, 7(3), 55.CrossRef
44.
Matza, L. S., Boye, K. S., Yurgin, N., Brewster-Jordan, J., Mannix, S., Shorr, J. M., et al. (2007). Utilities and disutilities for type 2 diabetes treatment-related attributes. Quality of Life Research, 16(7), 1251–1265.CrossRefPubMed
45.
Valensi, P., Benroubi, M., Borzi, V., Gumprecht, J., Kawamori, R., Shaban, J., et al. (2008). IMPROVE Study Group Expert Panel: The IMPROVE TM study—a multinational, observational study in type 2 diabetes: baseline characteristics from eight national cohorts. International Journal of Clinical Practice, 62(11), 1809–1819.CrossRefPubMed
Metadata
Title
Patient treatment satisfaction after switching to NovoMix® 30 (BIAsp 30) in the IMPROVE™ study: an analysis of the influence of prior and current treatment factors
Authors
Meryl Brod
Paul Valensi
Joseph A. Shaban
Don M. Bushnell
Torsten L. Christensen
Publication date
01-11-2010
Publisher
Springer Netherlands
Published in
Quality of Life Research / Issue 9/2010
Print ISSN: 0962-9343
Electronic ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-010-9699-0

Other articles of this Issue 9/2010

Quality of Life Research 9/2010 Go to the issue

BriefCommunication

Validity and reliability of the Bengali version of the Hepatitis Quality of Life Questionnaire

OriginalPaper

Five-year stability in associations of health-related quality of life measures in community-dwelling older adults: the Rancho Bernardo Study

OriginalPaper

HIV and COPD: impact of risk behaviors and diseases on quality of life

OriginalPaper

Physical activity in different domains and health-related quality of life: a population-based study

OriginalPaper

Isolated sleep paralysis linked to impaired nocturnal sleep quality and health-related quality of life in Chinese-Taiwanese patients with obstructive sleep apnea

OriginalPaper

Patient-reported outcomes measurement information system (PROMIS) domain names and definitions revisions: further evaluation of content validity in IRT-derived item banks